Business Description
Pliant Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US7291391057
Share Class Description:
FRA:9PT: Ordinary SharesDescription
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 43.46 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.87 | |||||
| Beneish M-Score | 0.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -76 | |||||
| 3-Year EBITDA Growth Rate | -12.6 | |||||
| 3-Year EPS without NRI Growth Rate | -12.1 | |||||
| 3-Year FCF Growth Rate | -3.2 | |||||
| 3-Year Book Growth Rate | -0.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.73 | |||||
| 9-Day RSI | 23.35 | |||||
| 14-Day RSI | 27.74 | |||||
| 6-1 Month Momentum % | 4.76 | |||||
| 12-1 Month Momentum % | -51.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.72 | |||||
| Quick Ratio | 17.72 | |||||
| Cash Ratio | 17.33 | |||||
| Days Sales Outstanding | 481.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19 | |||||
| Shareholder Yield % | -38.32 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -11654.75 | |||||
| Net Margin % | -10211.14 | |||||
| FCF Margin % | -7396.13 | |||||
| ROE % | -33.82 | |||||
| ROA % | -31.32 | |||||
| ROIC % | -1089.73 | |||||
| ROC (Joel Greenblatt) % | -2108.88 | |||||
| ROCE % | -32.75 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 424.29 | |||||
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.5 | |||||
| EV-to-EBIT | -1.46 | |||||
| EV-to-Forward-EBIT | -0.55 | |||||
| EV-to-EBITDA | -1.48 | |||||
| EV-to-Revenue | 147.92 | |||||
| EV-to-Forward-Revenue | 467.43 | |||||
| EV-to-FCF | -1.99 | |||||
| Price-to-Net-Current-Asset-Value | 1.53 | |||||
| Price-to-Net-Cash | 1.56 | |||||
| Earnings Yield (Greenblatt) % | -68.49 | |||||
| FCF Yield % | -16.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pliant Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.473 | ||
| EPS (TTM) (€) | -2.561 | ||
| Beta | 0.29 | ||
| Volatility % | 51.82 | ||
| 14-Day RSI | 27.74 | ||
| 14-Day ATR (€) | 0.382994 | ||
| 20-Day SMA (€) | 12.64 | ||
| 12-1 Month Momentum % | -51.82 | ||
| 52-Week Range (€) | 10.8 - 25 | ||
| Shares Outstanding (Mil) | 60.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pliant Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pliant Therapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pliant Therapeutics Inc Frequently Asked Questions
What is Pliant Therapeutics Inc(FRA:9PT)'s stock price today?
The current price of FRA:9PT is €11.20. The 52 week high of FRA:9PT is €25.00 and 52 week low is €10.80.
When is next earnings date of Pliant Therapeutics Inc(FRA:9PT)?
The next earnings date of Pliant Therapeutics Inc(FRA:9PT) is 2024-05-09 Est..
Does Pliant Therapeutics Inc(FRA:9PT) pay dividends? If so, how much?
Pliant Therapeutics Inc(FRA:9PT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers